Wockhardt eyes ₹1,000 crore India opportunity from new antibiotic
Habil F Khorakiwala, Founder Chairman of Wockhardt Group plans to file for DCGI approval for its new antibiotic in the coming months, with hopes of faster clearance under the government’s revised drug approval guidelines.